Market closed

Kalaris Therapeutics/$KLRS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Kalaris Therapeutics

Kalaris Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing therapeutics. Kalaris is developing TH103, a novel, clinical stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body native, highest affinity VEGF receptor 1.

Ticker

$KLRS
Trading on

Industry

Biotechnology

Employees

14

KLRS Metrics

BasicAdvanced
$132M
-
-$10.44
-
-
$132M
$12.90
$7.08
0.105
0.066
-39.327
-1.27%
-681.04%
270.05%
-0.49
-0.49
-2.27
330.98%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $KLRS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Kalaris Therapeutics stock?

Kalaris Therapeutics (KLRS) has a market cap of $132M as of April 05, 2025.

What is the P/E ratio for Kalaris Therapeutics stock?

The price to earnings (P/E) ratio for Kalaris Therapeutics (KLRS) stock is 0 as of April 05, 2025.

Does Kalaris Therapeutics stock pay dividends?

No, Kalaris Therapeutics (KLRS) stock does not pay dividends to its shareholders as of April 05, 2025.

When is the next Kalaris Therapeutics dividend payment date?

Kalaris Therapeutics (KLRS) stock does not pay dividends to its shareholders.

What is the beta indicator for Kalaris Therapeutics?

Kalaris Therapeutics (KLRS) does not currently have a Beta indicator.